The Inertia on MSN4d
The Best Water Shoes of 2024
We tested the best water shoes, from sandals to active hikers, classic clogs to hybrids. Check out our favorites based on ...
GearJunkie on MSN5d
The Best Camp Shoes of 2024
When the time comes, slipping into a good pair of camp shoes offers the perfect cozy conclusion to your day. Check out our ...
Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year, or ...
The trick is to not be bound by socks from cycling brands. My top pick, Hollow Crew socks are just from a general use sock brand, but they are made from alpaca wool. Likewise, my pick for the best ...
All products are independently selected by our editors. If you buy something, we may earn an affiliate commission. If you’ve ever dealt with sore, crampy legs (maybe after a long flight or a ...
On October 31, 2024, the European Commission issued a fine of €462.6 million to Teva Pharmaceuticals, citing abuse of its market dominance by delaying competition for Copaxone, a leading multiple ...
Now it is betting on a shoe that is made with a spray and feels more like a sock. The unconventional shoe is the result of a new technology that sprays the upper part of the sneaker onto a foot ...
If you think that all socks are the same, you have never tried Bombas socks. Bombas socks are a cult-favorite among runners in particular because of how comfortable, durable and stylish they are.
To do that, Teva conducted a "disparagement campaign" against Synthon, the only other company with an authorised drug in Europe containing glatiramer acetate, the Commission said in a statement.
European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA-0.99%decrease; red down pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...
Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...